Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

被引:2
|
作者
Wang, Saikun [1 ]
Zhu, Ruiting [1 ]
Zhang, Chengwei [2 ]
Guo, Yingze [1 ]
Lv, Mengjiao [1 ]
Zhang, Changyue [1 ]
Bian, Ce [1 ]
Jiang, Ruixue [1 ]
Zhou, Wei [3 ]
Guo, Lirong [1 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Jilin, Peoples R China
[2] Second Hosp Jilin Univ, Dept Anesthesiol, Changchun, Jilin, Peoples R China
[3] First Hosp Jilin Univ, Changchun, Jilin, Peoples R China
来源
PLOS ONE | 2023年 / 18卷 / 10期
关键词
CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; MYOCARDIAL INJURY; CRITICAL ILLNESS; MORTALITY; SEVERITY; OUTCOMES; DEATH; PREDICTORS; SARS-COV-2;
D O I
10.1371/journal.pone.0292021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients with pre-existing CHD remains uncertain primarily due to the limited number of patients in existing studies. This study aimed to investigate the impacts of pre-existing CHD on the prognosis of COVID-19 patients. Five electronic databases were searched for eligible studies. This article focused on cohort and case-control studies involving the prognosis of COVID-19 patients with pre-existing CHD. The meta-analysis was performed using a random effects model. The odds ratios (ORs) and 95% confidence intervals (CIs) were used as valid indicators. The study was registered in PROSPERO with the identifier: CRD42022352853. A total of 81 studies, involving 157,439 COVID-19 patients, were included. The results showed that COVID-19 patients with pre-existing CHD exhibited an elevated risk of mortality (OR = 2.45; 95%CI: [2.04, 2.94], P < 0.001), severe/critical COVID-19 (OR = 2.57; 95%CI: [1.98, 3.33], P < 0.001), Intensive Care Unit or Coronary Care Unit (ICU/CCU) admission: (OR = 2.75, 95%CI: [1.61, 4.72], P = 0.002), and reduced odds of discharge/recovery (OR = 0.43, 95%CI: [0.28, 0.66], P < 0.001) compared to COVID-19 patients without pre-existing CHD. Subgroup analyses indicated that the prognosis of COVID-19 patients with pre-existing CHD was influenced by publication year, follow-up duration, gender, and hypertension. In conclusion, pre-existing CHD significantly increases the risk of poor prognosis in patients with COVID-19, particularly in those male or hypertensive patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] PRE-EXISTING CORONARY ARTERY DISEASE AMONG COVID-19 PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Zuin, M.
    Rigatelli, G.
    Bilato, C.
    Ribichini, F.
    Roncon, L.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [2] Prevalence and clinical outcomes of COVID-19 in patients with pre-existing celiac disease: A systematic review and meta-analysis
    Rathore, Sawai Singh
    Velasquez-Botero, Felipe
    Nieto-Salazar, Maria Alejandra
    Flowers, Thomas C.
    Hasan, Jamal
    Parashar, Ashwani Kumar
    Tanveer, Khurram
    Aneis, Hamam
    Buremoh, Ayotunde Isaac
    Yusuf, Keturah
    Khalil, Khalil
    Toro-Velandia, Adriana Carolina
    Sabeeh, Shireen Kh.
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (03)
  • [3] Prevalence of pre-existing peripheral artery disease in COVID-19 patients and relative mortality risk: Systematic review and meta-analysis
    Zuin, Marco
    Rigatelli, Gianluca
    Bilato, Marco J.
    Bilato, Claudio
    Roncon, Loris
    VASCULAR, 2023, 31 (06) : 1103 - 1109
  • [4] Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis
    Urvish Patel
    Preeti Malik
    Dhaivat Shah
    Achint Patel
    Mandip Dhamoon
    Vishal Jani
    Journal of Neurology, 2021, 268 : 240 - 247
  • [5] Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis
    Ssentongo, Paddy
    Ssentongo, Anna E.
    Heilbrunn, Emily S.
    Ba, Djibril M.
    Chinchilli, Vernon M.
    PLOS ONE, 2020, 15 (08):
  • [6] Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis
    Alzoughool, Foad
    Abumweis, Suhad
    Alanagreh, Lo'ai
    Atoum, Manar
    OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2022, 13 (01) : 37 - 50
  • [7] Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis
    Ganesh, Adithan
    Randall, Michael D.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2642 - 2656
  • [8] Pre-existing sleep disturbances and risk of COVID-19: a meta-analysis
    Zhou, Jiawei
    Li, Xia
    Zhang, Ting
    Liu, Ziyan
    Li, Peng
    Yu, Na
    Wang, Wei
    ECLINICALMEDICINE, 2024, 74
  • [9] COVID-19 AND OBESITY: A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE PRE-EXISTING CLINICAL CONDITIONS, COVID-19 SYMPTOMS, LABORATORY FINDINGS AND CLINICAL OUTCOMES
    Ferreira, Maria Edilaine Rosario
    de Andrade, Arthur Vinicius Santos
    Queiroz, Alex Andre Ferreira
    Martins-Filho, Paulo Ricardo
    Neves, Eduardo Luis de Aquino
    de Carvalho, Fernanda Oliveira
    Araujo, Adriano Antunes de Souza
    Silva, Erika Ramos
    Nunes, Paula Santos
    EXCLI JOURNAL, 2021, 20 : 1610 - 1614
  • [10] COVID-19 and coronary artery disease; A systematic review and meta-analysis
    Hajikhani, Bahareh
    Safavi, Mahshid
    Bostanshirin, Nazila
    Sameni, Fatemeh
    Ghazi, Mona
    Yazdani, Shahrooz
    Nasiri, Mohammad Javad
    Khosravi-Dehaghi, Nafiseh
    Noorisepehr, Negin
    Sayyari, Saba
    Dadashi, Masoud
    NEW MICROBES AND NEW INFECTIONS, 2023, 53